Market Place
Sourcing Support
ProSomnus Sleep Tech Reports Record Revenues Post-Reorganization
07 Aug 2024 //
GLOBENEWSWIRE
ProSomnus Abstracts On Sleep Disorders To Be Presented At SLEEP 2024
30 May 2024 //
GLOBENEWSWIRE
ProSomnus Announces Strong First Quarter 2024 Revenue Growth
16 May 2024 //
GLOBENEWSWIRE
ProSomnus Abstracts Accepted At 2024 Dental Sleep Medicine Meeting
13 May 2024 //
GLOBENEWSWIRE
Four Abstracts Feature ProSomnus Device At Dental Sleep Meeting
09 May 2024 //
GLOBENEWSWIRE
ProSomnus Strategic Actions For Long-Term Success Positioning
08 May 2024 //
GLOBENEWSWIRE
ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results
26 Mar 2024 //
GLOBENEWSWIRE
ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Business Update Call
15 Mar 2024 //
GLOBENEWSWIRE
ProSomnus Reports Successful Pilot Study Validation of Remote Patient
22 Feb 2024 //
GLOBENEWSWIRE
ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Update Call
20 Feb 2024 //
GLOBENEWSWIRE
ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
30 Jan 2024 //
GLOBENEWSWIRE
ProSomnus Poised to Support Obstructive Sleep Apnea Patients
29 Jan 2024 //
GLOBENEWSWIRE
ProSomnus Comments on Insurance Coverage Policy Update for Central Sleep Apnea
08 Jan 2024 //
GLOBENEWSWIRE
ProSomnus Reports Record Third Quarter 2023 Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
ProSomnus Announces Third Quarter 2023 Investor Call and Business Update
31 Oct 2023 //
GLOBENEWSWIRE
ProSomnus Announces Participation in the 2023 Opportunities Conference
03 Oct 2023 //
GLOBENEWSWIRE
ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations
21 Sep 2023 //
GLOBENEWSWIRE
ProSomnus Precision Obstructive Sleep Apnea Devices to be Featured
14 Sep 2023 //
GLOBENEWSWIRE
ProSomnus Reports Record Second Quarter 2023 Top-Line Financial Results
03 Aug 2023 //
GLOBENEWSWIRE
ProSomnus to Design Head-to-Head Trial vs. Hypoglossal Nerve Stimulation
13 Jul 2023 //
GLOBENEWSWIRE
ProSomnus Announces Second Quarter 2023 Investor Call and Business Update
06 Jul 2023 //
GLOBENEWSWIRE
71% of Self-identified Snorers Have Never Consulted a Healthcare Professional
28 Jun 2023 //
GLOBENEWSWIRE
Data Presented at the 2023 American Academy of Dental Sleep Medicine
30 May 2023 //
GLOBENEWSWIRE
ProSomnus Reports First Quarter 2023 Financial Results
09 May 2023 //
GLOBENEWSWIRE
ProSomnus Announces Q1 2023 Investor Call & Participation Conferences
26 Apr 2023 //
GLOBENEWSWIRE
Study to be Presented at ERS Demonstrates Efficacy of ProSomnus Oral Appliances
24 Apr 2023 //
GLOBENEWSWIRE
ProSomnus® Announces Publication of Four Accepted Abstracts
18 Apr 2023 //
GLOBENEWSWIRE
ProSomnus Receives U.S. Utility Patent Covering Iterative Titration Technology
05 Apr 2023 //
GLOBENEWSWIRE
ProSomnus Reports Fourth Quarter and Fiscal Year 2022 Financial Results
30 Mar 2023 //
GLOBENEWSWIRE
ProSomnus to Report Fourth Quarter and Full Year 2022 Financial Results
16 Mar 2023 //
GLOBENEWSWIRE
ProSomnus Announces Acceptance of Abstract at European Respiratory Society
10 Mar 2023 //
GLOBENEWSWIRE
ProSomnus® Appoints Brian Dow as Chief Financial Officer
01 Mar 2023 //
GLOBENEWSWIRE
ProSomnus to Present at Two Upcoming Investor Conferences in March 2023
01 Mar 2023 //
GLOBENEWSWIRE
ProSomnus Provides Business Update and 2022 Revenue Guidance
01 Feb 2023 //
GLOBENEWSWIRE
ProSomnus Announces Acceptance of Abstract for Oral Presentation at Conference
26 Jan 2023 //
GLOBENEWSWIRE
